New liquid flu medicine study for children
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study tests a new liquid medicine called suraxavir marboxil for children with the flu. It aims to see if the medicine safely reduces flu symptoms and helps kids recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 2 and 12 years old and weigh at least 10 kg (about 22 lbs).
- They must have a confirmed flu infection (positive rapid test) and a fever (ear temp ≥100.4°F or armpit ≥99.5°F).
- They must have at least one moderate or severe flu symptom like cough, stuffy nose, or runny nose.
- Symptoms (fever and/or respiratory symptom) must have started less than 48 hours ago.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if taking suraxavir marboxil or oseltamivir can stop the flu from spreading to people sharing a hospital room with a patient who has the flu.
This study tests how well a single-dose flu treatment (baloxavir marboxil) works for children with the flu and whether it stops the flu from spreading to family members. If your child has early flu symptoms and lives with others, participation could help protect your household.
This Phase 2 study compares antiviral medicines in adults who have early, flu-like symptoms and test positive for influenza. It aims to see which antiviral treatment works best and is safe for people treated soon after symptoms start.
This study tests a new medicine called TRX-100 to see if it can help fight the flu. Healthy volunteers will be exposed to the influenza A virus in a controlled setting to see how the medicine works.
This study tests an experimental antiviral pill called Onradivir for teenagers (ages 12 to 17) with uncomplicated influenza A. It aims to see if the drug can safely shorten flu symptoms and help you recover faster.
This trial tests whether two flu medicines—baloxavir and oseltamivir—work better to treat influenza in people with weakened immune systems (like transplant or blood cancer patients). It may help reduce severe complications, especially when flu affects the lungs or is at high risk to do so.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.